NIH-funded research NIH-funded research

Consortium hub for early liver cancer detection and data coordination

Official title: Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)

Funded at Fred Hutchinson Cancer Center · NIH-11178110 · Data updated 2026-11-12

This project builds a central hub that helps researchers find and confirm blood and tissue markers to catch liver cancer earlier in people with cirrhosis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 17, 2018
Project endAugust 31, 2028
Funding year2025
Award (this year)$700,360
NIH project number5U24CA230144-09
Project IDNIH-11178110 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with cirrhosis or other chronic liver disease who are under surveillance for liver cancer or who are willing to donate samples for biomarker research.

Less likely to help

People without liver disease or those needing immediate treatment for advanced cancer are unlikely to get direct clinical benefit from this coordinating center.

What this research studies

This coordinating center brings together scientists across hospitals and labs to speed up work on early liver cancer detection. It creates and maintains secure databases and biorepositories where clinical data and patient samples are stored and shared. The center also helps design studies, provides statistical and bioinformatics support (including AI tools), and runs meetings to prioritize the most promising biomarkers. By standardizing procedures and pooling data, the group aims to make validation studies faster and more reliable.

Why it matters

Potential benefit: If successful, this work could help detect liver cancer earlier in high-risk patients and improve how doctors monitor people with cirrhosis.

How similar studies have gone: Previous multi-center biomarker efforts have produced promising leads but translating those markers into routine clinical tests has been challenging and needs coordinated validation.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Feng, Ziding — Fred Hutchinson Cancer Center
  • Study coordinator: Feng, Ziding

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.